Zinc treatment prevents dysmenorrhea

Medical Hypotheses

Volumn 69, Issue 2, 2007, Pages 297-301

  Eby, George A ^a  

^a George Eby Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLUCONATE ZINC; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROSTAGLANDIN; ZINC ACETATE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG MECHANISM; DYSMENORRHEA; FEMALE; HUMAN; MICROCIRCULATION; NAUSEA; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN SYNTHESIS; UTERUS BLOOD FLOW; UTERUS CONTRACTION;

ADOLESCENT; ADULT; ANIMALS; DYSMENORRHEA; FEMALE; HUMANS; MIDDLE AGED; ZINC;

EID: 34249296357     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.12.009     Document Type: Article

References (14)

1. Marjoribanks J., Proctor M.L., and Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 4 (2003) CD001751
2. Eby G.A., Davis D.R., and Halcomb W.W. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 25 (1984) 20-24
3. Kelly R.W., and Abel M.H. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biol Reprod 28 (1983) 883-889
4. Goei G.S., Ralston J.L., and Abraham G.E. Dietary patterns of patients with premenstrual tension. J Appl Nutr 34 (1982) 1-8
5. Kolodsky J. Nutrients to help uncramp your style. Prevention November (1982) 143-148
6. Abraham G.E. The calcium controversy. J Appl Nutr 34 (1982) 69-73
7. Prasad A.S., Fitzgerald J.T., Bao B., Beck F.W., and Chandrasekar P.H. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133 (2000) 245-252
8. Eby G.A., and Halcomb W.W. High-dose zinc to terminate angina pectoris: a review and hypothesis for action by ICAM inhibition. Med Hypotheses 66 (2006) 169-172
9. Sugino N., Karube-Harada A., Sakata A., Takiguchi S., and Kato H. Different mechanisms for the induction of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone in human endometrial stromal cells. Hum Reprod 17 7 (2002) 1709-1714 July
10. Prasad A.S., Bao B., Beck F.W.J., Kucuk O., and Sarkar F.H. Antioxidant effect of zinc in humans. Free Radic Biol Med 37 (2004) 1182-1190
11. Bashford C.L., Rodrigues L., and Pasternak C.A. Protection of cells against membrane damage by haemolytic agents: divalent cations and protons act at the extracellular side of the plasma membrane. Biochim Biophys Acta 983 (1989) 56-64
12. Seo S.S., Song Y.S., Kang D.H., Park I.A., Bang Y.J., Kang S.B., and Lee H.P. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Gynecol Oncol 92 (2004) 927-935
13. Fong L.Y., Zhang L., Jiang Y., and Farber J.L. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. J Natl Cancer Inst 97 (2005) 40-50
14. Siepmann M., Spank S., Kluge A., Schappach A., and Kirch W. The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men. Int J Clin Pharmacol Therap 43 (2005) 562-565